The PPARγ ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis

Pancreas

Volumn 27, Issue 1, 2003, Pages 58-66

  Hashimoto, Koji ^a   Ethridge, Richard T ^a   Saito, Hiroshi ^a   Rajaraman, Srinivasan ^a   Evers, B Mark ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

15d PGJ2; Acute pancreatitis; COX 2; NF B; PPAR agonists

Indexed keywords

CERULETIDE; CYCLOOXYGENASE 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D2; PROSTAGLANDIN D2 DERIVATIVE; SODIUM CHLORIDE; 15 DEOXYPROSTAGLANDIN J2; 15-DEOXYPROSTAGLANDIN J2; CELL RECEPTOR; DRUG DERIVATIVE; ISOENZYME; MESSENGER RNA; PROSTAGLANDIN SYNTHASE; TRANSCRIPTION FACTOR;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; DNA BINDING; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EDEMA; FEMALE; GENE INDUCTION; HISTOPATHOLOGY; IMMUNOBLOTTING; METABOLITE; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS NECROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RECEPTOR AFFINITY; REGULATORY MECHANISM; TISSUE LEVEL; TRANSCRIPTION REGULATION; ACUTE DISEASE; ANIMAL; BLOOD; CELL NUCLEUS; CHEMICALLY INDUCED DISORDER; ENZYMOLOGY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREATITIS; PATHOLOGY; PROTEIN TRANSPORT; TIME; WESTERN BLOTTING;

ACUTE DISEASE; ANIMALS; BLOTTING, WESTERN; CAERULEIN; CELL NUCLEUS; CYCLOOXYGENASE 2; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION REGULATION; I-KAPPA B PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; ISOENZYMES; LIGANDS; MICE; NF-KAPPA B; PANCREATITIS; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN TRANSPORT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 0038121646     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200307000-00009     Document Type: Article

References (68)

1. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med. 1994;330:1198-1210.
2. Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J Med. 1999;340: 1412-1417
3. Ho HS, Frey CF. Gastrointestinal and pancreatic complications associated with severe pancreatitis. Arch Surg. 1995;130:817-823.
4. Beger HG, Rau B, Mayer J, et al. Natural course of acute pancreatitis. World J Surg. 1997;21:130-135.
5. Saluja AK, Steer MLP. Pathophysiology of pancreatitis: role of cytokines and other mediators of inflammation. Digestion 1999;60(Suppl 1):27-33.
6. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg. 1998;175:76-83.
7. Rongione AJ, Kusske AM, Kwan K, et al. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997;112:960-967.
8. Norman J, Franz M, Messina J, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995;117:648-655.
9. Frossard JL, Saluja A, Bhagat L, et al. The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 1999;116:694-701.
10. Zaninovic V, Gukovskaya AS, Gukovsky I, et al. Cerulein upregulates ICAM-I in pancreatic acinar cells, which mediates neutrophil adhesion to these cells. Am J Physiol Gastrointest Liver Physiol. 2000;279:G666-G676.
11. Dunn JA, Li C, Ha T, et al. Therapeutic modification of nuclear factor kappa B binding activity and tumor necrosis factor-alpha gene expression during acute biliary pancreatitis. Am Surg. 1997;63:1036-1044.
12. Gukovsky I, Gukovskaya AS, Blinman TA, et al. Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol. 1998;275: G1402-G1414.
13. Steinle AU, Weidenbach H, Wagner M, et al. NF-kappaB/Rel activation in cerulein pancreatitis. Gastroenterology 1999;116:420-430.
14. Hietaranta AJ, Saluja AK, Bhagat L, et al. Relationship between NF-kappaB and trypsinogen activation in rat pancreas after supramaximal caerulein stimulation. Biochem Biophys Res Commun. 2001;280:388-395.
15. Ghosh S, Regulation of inducible gene expression by the transcription factor NF-kappaB. Immunol Res. 1999;19:183-189.
16. Mercurio F, Manning AM. NF-kappaB as a primary regulator of the stress response. Oncogene 1999;18:6163-6171.
17. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-683.
18. May MJ, Ghosh S. Signal transduction through NF-kappa B. Immunol Today 1998;19:80-88.
19. Satoh A, Shimosegawa T, Fujita M, et al. Inhibition of nuclear factor-kappaB activation improves the survival of rats with taurocholate pancreatitis. Gut 1999; 44:253-258.
20. Vaquero E, Gukovsky I, Zaninovic V, et al. Localized pancreatic NF-kappaB activation and inflammatory response in taurocholate-induced pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2001;280:G1197-G1208.
21. Ethridge RT, Hashimoto K, Chung DH, et al. Selective inhibition of NF-kappaB attenuates the severity of cerulein-induced acute pancreatitis. J Am Coll Surg. 2002;195:497-505.
22. Yamamoto K, Arakawa T, Ueda N, et al. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem. 1995;270:31315-31320.
23. Schmedtje JF Jr, Ji YS, Liu WL, et al. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem. 1997;272:601-608.
24. Ethridge RT, Chung DH, Slogoff M, et al. Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 2002;123:1311-1322.
25. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-839.
26. Kliewer SA, Lehmann JM, Willson TM. Orphan nuclear receptors: shifting endocrinology into reverse. Science 1999;284:757-760.
27. Forman BM, Tontonoz P, Chen J, et al. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995;83: 803-812.
28. Kliewer SA, Lenhard JM, Willson TM, et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995;83:813-819.
29. Chawla A, Schwarz EJ, Dimaculangan DD, et al. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 1994; 135:798-800.
30. Nolan JJ, Ludvik B, Beerdsen P, et al. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med. 1994;331:1188-1193.
31. Ricote M, Li AC, Willson TM, et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391:79-82.
32. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998;391:82-86.
33. Pasceri V, Wu HD, Willerson JT, et al. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation 2000;101:235-238.
34. Inoue H, Tanabe T, Umesono K. Feedback control of cyclooxygenase-2 expression through PPARgamma. J Biol Chem. 2000;275:28028-28032.
35. Su CG, Wen X, Bailey ST, et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest. 1999;104:383-389.
36. Kawahito Y, Kondo M, Tsubouchi Y, et al. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest. 2000;106:189-197.
37. Nakajima A, Wada K, Miki H, et al. Endogenous PPAR gamma mediates antiinflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 2001;120:460-469.
38. Gomez G, Townsend CM Jr, Green DW, et al. Protective action of luminal bile salts in necrotizing acute pancreafitis in mice. J Clin Invest. 1990;86:323-331.
39. Ethridge RT, Ehlers RA, Hellmich MR, et al. Acute pancreatitis results in induction of heat shock proteins 70 and 27 and heat shock factor-1. Pancreas 2000;21:248-256.
40. Schreiber E, Matthias P, Muller MM, et al. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989;17:6419.
41. Evers BM, Zhou Z, Celano P, et al. The neurotensin gene is a downstream target for Ras activation. J Clin Invest. 1995;95:2822-2830.
42. Schmidt J, Lewandrowski K, Fernandez-del Castillo C, et al. Histopathologic correlates of serum amylase activity in acute experimental pancreatitis. Dig Dis Sci. 1992;37:1426-1433.
43. Saito H, Papaconstantinou J. Age-associated differences in cardiovascular inflammatory gene induction during endotoxic stress. J Biol Chem. 2001;276: 29307-29312.
44. Evers BM, Wang X, Zhou Z, et al. Characterization of promoter elements required for cell-specific expression of the neurotensin/neuromedin N gene in a human endocrine cell line. Mol Cell Biol. 1995;15:3870-3881.
45. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;262: 8409-8419.
46. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A 1984; 81:1991-1995.
47. Bishop-Bailey D, Hla T. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2. J Biol Chem. 1999;274:17042-17048.
48. , Tsubouchi Y, Sano H, Kawahito Y, et al. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem Biophys Res Commun. 2000;270:400-405.
49. Needleman P, Turk J, Jakschik BA, et al. Arachidonic acid metabolism. Annu Rev Biochem. 1986;55:69-102.
50. Guan Z, Buckman SY, Miller BW, et al. Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem. 1998;273: 28670-28676.
51. Diaz A, Chepenik KP, Korn JH, et al. Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts. Exp Cell Res. 1998;241:222-229.
52. Niiro H, Otsuka T, Ogami E, et al. MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. Biochem Biophys Res Commun. 1998;250:200-205.
53. Inagaki T, Hoshino M, Hayakawa T, et al. Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis. Pancreas 1997;14:1-8.
54. Health DI, Cruicks HA, Gudgeon M, et al. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1992;34:41-45.
55. Blinman TA, Gukovsky I, Mouria M, et al. Activation of pancreatic acinar cells on isolation from tissue: cytokine upregulation via p38 MAP kinase. Am J Physiol Cell Physiol. 2000;279:C1993-C2003.
56. Norman JG, Fink GW, Denham W, et al. Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci. 1997;42:1783-1788.
57. Bhatia M. Brady M, Shokuhi S, et al. Inflammatory mediators in acute pancreatitis. J Pathol. 2000;190:117-125.
58. Shimizu K, Shiratori K, Hayashi N, et al. Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis. Pancreas 2002;24:184-190.
59. Chinetti G, Griglio S, Antonucci M. et al. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem. 1998;273:25573-25580.
60. Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev. 1992;127:25-50.
61. Suzuki S, Miyasaka K, Jimi A, et al. Induction of acute pancreatitis by cerulein in human IL-6 gene transgenic mice. Pancreas 2000;21:86-92.
62. Shimada M, Andoh A, Hata K, et al. IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J Immunol. 2002; 168:861-868.
63. Fu JY, Masferrer JL, Seibert K, et al. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 1990; 265:16737-16740.
64. Cuzzocrea S, Wayman NS, Mazzon E, et al. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. Mol Pharmacol. 2002;61:997-1007.
65. Subbaramaiah K, Lin DT, Hart JC, et al. Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2: evidence for involvement of activator protein-1 and CREB-binding protein/p300. J Biol Chem. 2001;276:12440-12448.
66. Tsubouchi Y, Kawahito Y, Kohno M, et al. Feedback control of the arachidonate cascade in rheumatoid synoviocytes by 15-deoxy-Delta(12,14)-prostaglandin J2. Biochem Biophys Res Commun. 2001;283:750-7455.
67. Janabi N. Selective inhibition of cyclooxygenase-2 expression by 15-deoxyDelta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages. J Immunol. 2002;168:4747-4755.
68. Straus DS, Pascual G, Li M, et al. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A. 2000;97:4844-4849.